Okuma K, Ariyoshi Y, Ota K
Gan To Kagaku Ryoho. 1986 Oct;13(10):3040-5.
Cardiotoxicity induced by mitoxantrone was studied in 50 closely followed patients receiving chemotherapy with mitoxantrone. Serial electrocardiograms were recorded. The electrocardiographic parameters (heart rate, P-Q interval, QRS interval, QRS voltage, and QTc interval) were analyzed. The patients who received mitoxantrone showed no significant changes in these parameters. Furthermore, in order to investigate the details of acute cardiotoxicity of mitoxantrone and adriamycin, Holter ECGs were recorded and some of the electrocardiographic parameters were analyzed. The basic rhythm was sinus rhythm in all cases except for only one case which developed intermittent atrial fibrillation after adriamycin therapy. No effect on the specialized conduction system was observed on either group. Supraventricular premature beat showed no significant changes, but ventricular premature beat showed a tendency to increase and the mode of appearance of the ventricular extrasystole was very dangerous in the adriamycin-administered group. Developed ST-T changes were also seen in the adriamycin group. In conclusion, mitoxantrone seemed to have less cardiotoxicity in comparison with that of adriamycin.
对50例接受米托蒽醌化疗且密切随访的患者进行了米托蒽醌所致心脏毒性的研究。记录系列心电图。分析心电图参数(心率、P-Q间期、QRS间期、QRS电压和QTc间期)。接受米托蒽醌治疗的患者这些参数无显著变化。此外,为了研究米托蒽醌和阿霉素急性心脏毒性的细节,记录了动态心电图并分析了一些心电图参数。除1例在阿霉素治疗后发生间歇性房颤外,所有病例的基本节律均为窦性节律。两组均未观察到对特殊传导系统有影响。室上性早搏无显著变化,但室性早搏有增加趋势,且在阿霉素给药组室性期前收缩的出现方式非常危险。阿霉素组也出现了ST-T改变。总之,与阿霉素相比,米托蒽醌似乎心脏毒性较小。